Literature DB >> 26491995

Sociodemographic and Clinical Features of Disruptive Mood Dysregulation Disorder: A Chart Review.

Evren Tufan1, Zehra Topal1, Nuran Demir1, Sarper Taskiran2, Uğur Savci1, Mehmet Akif Cansiz1, Bengi Semerci3.   

Abstract

OBJECTIVE: Disruptive mood dysregulation disorder (DMDD) is a novel diagnosis listed in Diagnostic and Statistical Manual of Mental Disorders, 5th ed. (DSM-5) to encompass chronic and impairing irritability in youth, and to help its differentiation from bipolar disorders. Because it is a new entity, treatment guidelines, as well as its sociodemographic and clinical features among diverse populations, are still not elucidated. Here, DMDD cases from three centers in Turkey are reported and the implications are discussed.
METHODS: The study was conducted at the Abant Izzet Baysal University Medical Faculty Department of Child and Adolescent Psychiatry (Bolu), and American Hospital and Bengi Semerci Institute (Istanbul) between August 2014 and October 2014. Records of patients were reviewed and features of patients who fulfilled criteria for DMDD were recorded. Data were analyzed with SPS Version 17.0 for Windows. Descriptive analyses, χ(2) test, and Mann-Whitney U test were used for analyses. Diagnostic consensus was determined via Cohen's κ constants. p was set at 0.01.
RESULTS: Thirty-six patients (77.8 % male) fulfilled criteria for DMDD. κ value for consensus between clinicians was 0.68 (p = 0.00). Mean age of patients was 9.0 years (S.D. = 2.5) whereas the mean age of onset for DMDD symptoms was 4.9 years (S.D. = 2.2). Irritability, temper tantrums, verbal rages, and physical aggression toward family members were the most common presenting complaints.
CONCLUSIONS: Diagnostic consensus could not be reached for almost one fourth of cases. Most common reasons for lack of consensus were problems in clarification of moods of patients in between episodes, problems in differentiation of normality and pathology (i.e., symptoms mainly reported in one setting vs. pervasiveness), and inability to fulfill frequency criterion for tantrums.

Entities:  

Mesh:

Year:  2015        PMID: 26491995     DOI: 10.1089/cap.2015.0004

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  6 in total

1.  Cognitive-Behavioral Therapy for a 9-Year-Old Girl With Disruptive Mood Dysregulation Disorder.

Authors:  Megan E Tudor; Karim Ibrahim; Emilie Bertschinger; Justyna Piasecka; Denis G Sukhodolsky
Journal:  Clin Case Stud       Date:  2016-09-22

2.  The Clinician Affective Reactivity Index: Validity and Reliability of a Clinician-Rated Assessment of Irritability.

Authors:  Simone P Haller; Katharina Kircanski; Argyris Stringaris; Michal Clayton; Hong Bui; Courtney Agorsor; Sofia I Cardenas; Kenneth E Towbin; Daniel S Pine; Ellen Leibenluft; Melissa A Brotman
Journal:  Behav Ther       Date:  2019-11-27

Review 3.  Diagnostic instruments for the assessment of disruptive mood dysregulation disorder: a systematic review of the literature.

Authors:  Ines Mürner-Lavanchy; Michael Kaess; Julian Koenig
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-07-07       Impact factor: 4.785

4.  Perinatal and postnatal risk factors for disruptive mood dysregulation disorder at age 11: 2004 Pelotas Birth Cohort Study.

Authors:  Tiago N Munhoz; Iná S Santos; Aluísio J D Barros; Luciana Anselmi; Fernando C Barros; Alicia Matijasevich
Journal:  J Affect Disord       Date:  2017-03-19       Impact factor: 4.839

5.  Children With Disruptive Mood Dysregulation Disorder and Psychopathological Risk in Their Mothers: The Function of Global DNA Methylation.

Authors:  Valeria Carola; Silvia Cimino; Silvia Bussone; Luca Cerniglia; Renata Tambelli
Journal:  Front Psychiatry       Date:  2021-01-27       Impact factor: 4.157

6.  Demographic and psychosocial profile of disruptive mood dysregulation disorder in Indian settings.

Authors:  Samiksha Sahu; Daniel Saldanha; Suprakash Chaudhury; Preethi Menon; Shivaji Marella; Vasdev Singh Kalkat
Journal:  Ind Psychiatry J       Date:  2021-03-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.